US Patent Issued to Dana-Farber Cancer Institute on Aug. 4 for "Cyano-pyrimidine inhibitors of EGFR/HER2" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,261, issued on Aug. 4, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Cyano-pyrimidine inhibitors of EGFR/HER2" was invented by Nathanael S. Gray (Boston) and John M. Hatcher (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides compounds of Formula (I):or a pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising compounds of Formula (I) or a pharmaceutically acceptable salt thereof which are inhibitors of EGFR and HER2 useful for the treatment of EGFR/HER2 susceptible disorders such as cancer, including cancer of the lung, colon, breast, and thyroid."

The patent was filed on Jan. 6...